89. リンパ脈管筋腫症 Lymphangioleiomyomatosis Clinical trials / Disease details
臨床試験数 : 39 / 薬物数 : 46 - (DrugBank : 20) / 標的遺伝子数 : 27 - 標的パスウェイ数 : 137
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT04388371 (ClinicalTrials.gov) | October 18, 2019 | 11/5/2020 | Glutamine PET Imaging in LAM | Glutamine PET Imaging in LAM | Lymphangioleiomyomatosis (LAM) | Drug: Glutamine | Vanderbilt University Medical Center | The LAM Foundation | Completed | 18 Years | N/A | Female | 5 | Phase 1 | United States |